Cargando…

Sudden death prevention in heart failure: The case of CIBIS III

Detalles Bibliográficos
Autores principales:	VANOLI, EMILIO, DEI CAS, LIVIO, WILLENHEIMER, RONNIE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184665/ https://www.ncbi.nlm.nih.gov/pubmed/21977254 http://dx.doi.org/10.4081/hi.2006.73

Ejemplares similares

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
por: Düngen, Hans-Dirk, et al.
Publicado: (2011)

Angiotensin receptor blockers in heart failure after the ELITE II trial
por: Willenheimer, Ronnie
Publicado: (2000)

Validation of the FEW16 questionnaire for the assessment of physical well‐being in patients with heart failure with reduced ejection fraction: results from the CIBIS‐ELD study
por: Tahirović, E., et al.
Publicado: (2015)

Stratification of the Risk of Sudden Death in Nonischemic Heart Failure
por: Pimentel, Maurício, et al.
Publicado: (2014)

Angiotensin Receptor Antagonists to Prevent Sudden Death in Heart Failure: Does the Dose Matter?
por: Francia, Pietro, et al.
Publicado: (2014)

Prediction of sudden death in elderly patients with heart failure
por: Ayesta, Ana, et al.
Publicado: (2018)

Primary results from the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE)
por: Aonuma, Kazutaka, et al.
Publicado: (2022)

Some Affections of the Heart Concerned in Sudden Death: III. The Cardiac Muscle
por: Fisher, Theodore
Publicado: (1907)

Heart and Sudden Death
por: Norell, Michael S.
Publicado: (1992)

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2011)

Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?
por: Lubsen, Jacobus
Publicado: (2000)

Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?
por: Hsia, Henry H, et al.
Publicado: (2000)

Sudden Heart Failure
Publicado: (1950)

Cardiac macrophages prevent sudden death during heart stress
por: Sugita, Junichi, et al.
Publicado: (2021)

Rationale and design of the HINODE study: Heart failure indication and sudden cardiac death prevention trial Japan
por: Yamasaki, Hiro, et al.
Publicado: (2021)

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
por: Teerlink, John R., et al.
Publicado: (2009)

Brain, heart, and sudden death
por: Oveisgharan, Shahram, et al.
Publicado: (2022)

Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death?
por: Goldstein, Sidney
Publicado: (2000)

Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update
por: Masarone, Daniele, et al.
Publicado: (2018)

Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction
por: Cho, Jae Hyung
Publicado: (2022)

Tricuspid valve myxoma in a patient with congestive heart failure
por: Vizzardi, Enrico, et al.
Publicado: (2010)

Endocannabinoids and cardiovascular prevention: real progress?
por: NODARI, SAVINA, et al.
Publicado: (2007)

Prevention of Sudden Cardiac Death
por: Francis, Johnson
Publicado: (2011)

Anemia and heart failure: a cause of progression or only a consequence?
por: METRA, MARCO, et al.
Publicado: (2007)

Device Therapy to Prevent Sudden Death in Patients with Structural Heart Disease
por: Sreeram, N, et al.
Publicado: (2010)

Prevented Sudden Cardiac Death and Neurologic Recovery in Inherited Heart Diseases
por: Hernández del Rincón, Juan P., et al.
Publicado: (2021)

Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death
por: Pino-Marín, Antonia, et al.
Publicado: (2021)

Case of Sudden Death from Fatty Degeneration of the Heart
por: Paxton,
Publicado: (1856)

Case of Sudden Death from (Supposed) Heart-Clot
Publicado: (1853)

Increased heart rate in high-risk hypertensives related to increased heart failure and sudden death
por: Aalbers, J
Publicado: (2010)

Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study)
por: Summerfield, NJ, et al.
Publicado: (2012)

Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials
por: Al-Gobari, Muaamar, et al.
Publicado: (2013)

Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2020)

The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
por: Gronda, Edoardo, et al.
Publicado: (2020)

Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results
por: Metra, Marco, et al.
Publicado: (2007)

Near-Universal Prevalence of Pneumocystis and Associated Increase in Mucus in the Lungs of Infants With Sudden Unexpected Death
por: Vargas, Sergio L., et al.
Publicado: (2013)

No effects on myocardial ischaemia in patients with stable ischaemic heart disease after treatment with ramipril for 6 months
por: Willenheimer, Ronnie, et al.
Publicado: (2001)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018)

Sudden infant death syndrome prevention
por: Jullien, Sophie
Publicado: (2021)

Secondary prevention of sudden cardiac death
por: Chatterjee, Neal A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_33hgnm2nav9267ao10uurfhlf4